The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …

Context Detection of clinically significant prostate cancer (PCa) is a major challenge. It has
been shown that multiparametric magnetic resonance imaging (mpMRI) facilitates …

OBJECTIVES: To present a summary of the 2007 version of the European Association of
Urology (EAU) guidelines on prostate cancer (PCa). METHODS: A literature review of the …

Purpose: An optimal prostate biopsy in clinical practice is based on a balance among
adequate detection of clinically significant prostate cancers (sensitivity), assuredness …

Targeted prostate biopsy is challenging because no currently established imaging modality
is both accurate for prostate cancer diagnosis and cost-effective for real-time procedure …

Background Prostate-specific antigen (PSA) is widely used to detect prostate cancer. The
low positive predictive value of elevated PSA results in large numbers of unnecessary …

Optimizing prostate cancer detection rates (CDRs) in clinical practice translates into defining
the ideal number and location of biopsy cores to maximize clinically significant cancer …

Objectives Primary objectives: to determine whether local anaesthetic transperineal prostate
(LATP) biopsy improves the detection of clinically significant prostate cancer (csPCa) …

CONTEXT: The number and location of biopsy cores and the interpretation of prostate
biopsy in different clinical settings remain the subjects of continuing debate. OBJECTIVE …

Background In active surveillance (AS) patients:(i) To compare the ability of a
multiparametric MRI (mpMRI)‐ultrasound biopsy system to detect clinically significant (CS) …